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Call for Papers
Special Issue on ‘‘Biomarkers for Diseases’’
The journal Genomics Proteomics & Bioinformatics (GPB) is now inviting
submissions for a special issue (to be published in June of 2015) on the topic of
‘‘Biomarkers for Diseases’’.
As an emerging index, disease biomarkers have demonstrated the potential application in
diagnosis and prognosis. The detection of the disease indicators at molecular level, DNA,
RNA, protein or metabolites, could gain highly sensitive and specific signals that truly reflect
the pathological changes and fully facilitate diagnostic analysis at early phase with invasive
mode. Revolution of high-throughput techniques, such as genome-sequencing and mass
spectrometers, greatly promotes the discovery and application of the disease biomarkers. The
existing disease biomarkers have covered nearly all the macromolecular categories as well as
their variants and modifications, including predisposing genetic variations (such as SNPs),
mutations, epigenetic modifications, miRNAs, splice isoforms, abnormal proteins and
autoantibodies. Although some biomarkers have been adopted in clinical practice, there are
still great needs for studies on identifying new ones, understanding the existing ones and
applying the well-studied ones in practice.
We are pleased to announce a special issue on ‘‘Biomarkers for Diseases’’ in GPB, which
is likely to provide a platform for the quality papers focusing on biomarker discovery and
application. Dr. Siqi Liu from Beijing Institute of Genomics, Chinese Academy of Sciences
and Dr. Edwin Wang from the National Research Council Canada are Guest Editors of this
issue. The topics may include (but not be limited to):
• Discovery of disease biomarkers using next-generation sequencing
• Epigenetic evidence and disease biomarkers
• Discovery of disease biomarkers through evaluation of gene expression
• Exploration and application of disease protein biomarkers using proteomic analysis
• Alternation of metabolic pathways responding to disease
• Integration of omics data for discovery of disease biomarkers
• High-throughput platforms for biomarker discovery
• Techniques for measurement of disease biomarkers in the clinical diagnosis
Original studies, reviews, methods, application notes, etc. are all welcome. The portfolio
will be open for incoming manuscripts till February 28, 2014.
Manuscripts can be submitted online at http://ees.elsevier.com/gpb/. The Guide for
Authors is also available on this web site. Note to mention that the submission is for this
special issue.
For further information, please contact us:
Dr. Liu (siqiliu@big.ac.cn);
Dr. Wang (Edwin.Wang@cnrc-nrc.gc.ca);
Editorial Office (editor@big.ac.cn).
